Inhibrx Biosciences Inc (INBX)
EBITDA Margin
-8832.46%
TTM · Period ending:
INBX EBITDA Margin
Latest reported-8832.46%period ending
Latest reported-8832.46%period ending
INBX TTM EBITDA Margin (-355.74% → -8832.46%)
TTM ebitda margin
High-resolution chart · PNG
INBX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -8,832.4615% | |
| -9,644.1538% | |
| -10,247.5% | |
| -11,076.9286% | |
| 866,811.5% | |
| 851,675% | |
| 95,878.6044% | |
| 89,708.8505% | |
| -13,482.5014% | |
| -11,735.0556% | |
| -36,008.6364% | |
| -24,173.2888% | |
| -10,954.9219% | |
| -5,869.5133% | |
| -2,357.3207% | |
| -1,437.6037% | |
| -1,185.1734% | |
| -1,048.6987% | |
| -1,025.9789% | |
| -673.3468% | |
| -528.0178% | |
| -520.5731% | |
| -644.1693% | |
| -1,269.3374% | |
| -1,851.3126% | |
| -437.5894% | |
| -244.7589% | |
| -137.3408% | |
| -153.3669% | |
| -355.7351% |